Hyperglycemia and hypoxia are interrelated in their teratogenic mechanism: Studies on cultured rat embryos

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 89, Issue 2, 2010, Pages 106-115

  Ornoy, Asher ^a   Rand, Shiran Bahat ^a   Bischitz, Noa ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; CATALASE; HYPOXIA INDUCIBLE FACTOR 1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYO GROWTH; EMBRYOTOXICITY; ENZYME ACTIVITY; HYPERGLYCEMIA; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TERATOGENESIS; YOLK SAC;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTIOXIDANTS; CATALASE; CELL HYPOXIA; EMBRYO CULTURE TECHNIQUES; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HYPERGLYCEMIA; LIPID PEROXIDATION; MALONDIALDEHYDE; MOLECULAR WEIGHT; OXIDATIVE STRESS; RATS; RATS, INBRED STRAINS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

ANIMALIA; RATTUS;

EID: 77951721709     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.20230     Document Type: Article

References (42)

1. Baeuerle PA, Henkel T. 1994. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179. (Pubitemid 2081202)
2. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L. 2004. Hyperglycemia regulates hypoxia-inducible factor 1 protein stability and function. Diabetes 53:3226-3232. (Pubitemid 39564499)
4. Cederberg J, Siman CM, Eriksson UJ. 2001. Combined treatment with vitamin E and vitamin C decrease oxidative stress and improve fetal outcome in experimental diabetic pregnancy. Pediatr Res 49:755-762. (Pubitemid 32522048)
5. Dai SY, Kanenishi K, Ueno M, Sakamoto H, Hata T. 2004. Hypoxia-inducible factor-2alpha is involved in enhanced apoptosis in the placenta from pregnancies with fetal growth restriction. Pathol Int 54:843-849. (Pubitemid 40065090)
6. Dohlen G, Carlsen H, Blomboff R, Thaulow E, Saugstat DO. 2005. Reoxygenation of hypoxic mice with 100% oxygen induces brain nuclear factor-kappa B. Pediatr Res 58:941-945. (Pubitemid 41511069)
7. Eriksson UJ, Borg LA, Forsberg H, Styrud J. 1991. Diabetic embryopathy: studies with animal and in vitro models. Diabetes 40(Suppl 2):94-98.
8. Gao W, Ferguson G, Connel P, Walshe T, Murphy R, Birney Y, O'Brien C, Cahill PA. 2007. High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF 1-dependent pathway. J Mol Cell Physiol 42:609-619. (Pubitemid 46349124)
9. Ghosh S, Karin M. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl):S81-S96.
10. Haddad JJ. 2002. Oxygen sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiology. Respir Res 3:26-53.
11. Halliwell B. 1997. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411:157-160.
12. Hockett PK, Emery SW, Hansen L, Masliah E. 2004. Evidence of oxidative stress in the brains of fetuses with CNS anomalies and Islet Cell hyperplasia. Pediatr Dev Pathol 7:370-379. (Pubitemid 39145708)
13. Howarth C, Gazis A, James D. 2007. Association of type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy. Diabet Med 24:1229-1234. (Pubitemid 47621803)
14. Huang D, Ou B, Hampsh-Woodill M, Flanagan JA, Deemer EK. 2002. Development and validation of oxygen radical absorbance capacity assay for lipophilic antioxidants using randomly methylated beta-cyclodextrin as the solubility enhancer. J Agric Food Chem 50:1815-1821. (Pubitemid 34259972)
15. Jawerbaum A, Higa R, White V, Capobianco E, Pustovrh C, Sinner D, Martínez N, González E. 2005. Peroxynitrites and impaired modulation of nitric oxide concentrations in embryos from diabetic rats during early organogenesis. Reproduction 130:695-703. (Pubitemid 41646054)
16. Kay HH, Tsoi S, Grindle K, Magness RR. 2006. Markers of oxidative stress in placental villi exposed to ethanol. J Soc Gynecol Invest 13:118-121. (Pubitemid 43155844)
17. Ke Q, Costa M. 2006. Hypoxia inducible factor-1 (HIF1). Mol Pharmacol 70:1469-1480.
18. Kohen R, Nyska A. 2002. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reaction and methods for their quantitation. Toxicol Pathol 30:620-650. (Pubitemid 36018731)
19. Koong AC, Chen KY, Giaccia AJ. 1994. Hypoxia causes the activation of nuclear factor kappa through the phosphorilation of I-κB on tyrosine residues. Cancer Res 54:1425-1430.
20. Li R, Chase M, Jung SK, Smith PJS, Locken MR. 2005. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 289:E591-E599. (Pubitemid 41356080)
21. Lyall F, Gibsonn JL, Greer TA, Brockman DE, Eis AL, Myatt L. 1998. Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care 21:1753-1758. (Pubitemid 28449820)
22. McCord JM, Fridovich I. 1988. Superoxide dismutase: the first twenty years (1968-1988). Free Radic Biol Med 5:363-369. (Pubitemid 19024286)
23. Mihara M, Uchiyama M. 1978. Determination of malondialdehyde precursors in tissues by thiobirbituric acid test. Annal Biochem 86:271-278. (Pubitemid 9050395)
24. Ornoy A. 2007. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol 24:31-41. (Pubitemid 47042350)
25. Ornoy A, Zaken V, Kohen R. 1999. The role of reactive oxygen species (ROS) in the diabetes-induced anomalies, in rat embryos in vitro: a reduction in antioxidant enzymes and low molecular weight antioxidants (LMWA) may be a causative factor for increased anomalies. Teratology 60:376-386.
26. Ream M, Ray AM, Chandra R, Chikaraishi DM. 2008. Early fetal hypoxia leads to growth restriction and myocardial thinning. Am J Physiol Regul Integr Comp Physiol 295:583-595.
27. Romeo G, Liu WH, Asnaghi V, Kern TS, Mara Lorenzil M. 2002. Activation of nuclear factor-B induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241-2247. (Pubitemid 34729031)
28. Rosenberger C, Khamaishi M, Abassi Z, Shilo V, Weksler-Zangen S, Goldfarb M, Zibertrest F, Eckardt KU, Rosen S, Heyman SN. 2008. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int 73:34-42. (Pubitemid 350273633)
29. Royds JA, Dower SK, Qwarnstrom EE, Lewis CE. 1998. Response of tumor cells to hypoxia: role of p53 and NF-κB. J Clin Pathol Mol Pathol 51:55-61. (Pubitemid 28261243)
30. Rulin L, Chase M, Jung SK, Smith PJS, Loeken MR. 2005. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab E591-E599. (Pubitemid 41356080)
31. Sarada S, Himadri P, Mishra C, Geetal P, Ram MS, Ilavazhagan G. 2008. role of oxidative stress and NF kappa B in hypoxia-induced pulmonary edema. Exp Biol Med 233:1088-1098.
32. Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL. 2000. Patterns of congenital anomalies and relationship to initial maternal fasting: glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 182:313-320. (Pubitemid 30127341)
33. Schreck R, Rieber P, Baeuerle PA. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. Embo J 10:2247-2258. (Pubitemid 21905698)
34. Sumbayev VV, Yasinska IM. 2006. Peroxynitrite as an alternative donor of oxygen in HIF-1alpha proline hydroxylation under low oxygen availability. Free Radic Res 40:631-635.
35. Thurman RG, Ley HG, Scholz R. 1972. Hepatic microsomal ethanol oxidation. Hydrogen peroxide formation and the role of catalase. Eur J Biochem 25:420-430.
36. Webster WS, Abela D. 2007. The effect of hypoxia in development. Birth Defects Res C 81:215-228.
37. Williamson JR, Cyhang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG. 1993. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813.
38. Yamada N, Horikawa Y, Oda N, Shihara N, Kishi S, Takeda J. 2005. Genetic variation in the hypoxia- inducible factor 1a gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metabol 90:5841-5847. (Pubitemid 41415501)
39. Zaken V, Kohen R, Ornoy A. 2000. The development of the antioxidant defense mechanism in young rat embryos in vivo and in vitro. Early Pregnancy Biol Med 4:110-123.
40. Zaken V, Kohen R, Ornoy A. 2001. Vitamins C and E improve rat embryonic antioxidant defense mechanism in diabetic culture medium. Teratology 64:33-44.
41. Zangen WS, Seonghun R, Ornoy A. 2006. The role of antioxidant enzymes and transcription factor NF-kappa B in Diabetic embryopathy in the Cohen diabetic rat model. Birth Defects Res A 76:107-114.
42. Zhang X, Ruiz B, Correa P, Miller MJ. 2000. Cellular dissociation of NF-kappaB and inducible nitric oxide synthase in Helicobacter pylori infection. Free Radic Biol Med 29:730-735.